For the Quarter Ending June 2023

North America:

Oxcarbazepine prices in the North American region concluded the second quarter of 2023 on a downtrend. The weak price trajectory at the beginning of Q2 could be attributed to sluggish demand and elevated stock levels, significantly impeding market fundamentals. Domestic sales suffered due to higher inflation, while new inquiries from the regional market remained subdued. Consequently, retailers grappled with excessive warehouse inventories that were built up during the pandemic to meet surging demand. Furthermore, imports at North American ports continued to decline. Despite Consumer Price Index (CPI) strengthening in some parts of the region, like the United States where it increased by 0.1% from May to June 2023, local demand saw minimal changes. This sustained the negative trajectory for Oxcarbazepine. Traders and suppliers hesitated to place future orders, focusing on destocking due to disrupted weather conditions in June.

Asia Pacific:

Throughout the second quarter of 2023, the prices of Oxcarbazepine, an Active Pharmaceutical Ingredient, plummeted both in the regional and overseas markets, following a bearish trajectory since the start of the year. In April, Oxcarbazepine prices experienced a significant decline compared to the previous month. This drop was attributed to reduced consumption of the API in the pharmaceutical and healthcare sectors, leading to increased product stockpiling in warehouses. Merchants became apprehensive, prompting significant destocking efforts. Moving toward mid-Q3, India's Purchasing Managers' Index (PMI) rose from 57.2 in April 2023 to 58.7 in May 2023. However, downstream sector inquiries remained weak. As Q2 concluded, Oxcarbazepine prices in the Indian market settled at USD 118,145.57/MT IP Ex-Vadodara, marking a 4.20% decrease from the previous month. Moreover, India's exports experienced a fifth consecutive monthly decline in June 2023, attributed to sluggish economies in North America and the EU, impacting trade activities due to a combination of slowdown and inflationary pressure.

Oxcarbazepine Prices: https://www.chemanalyst.com/Pricing-data/oxcarbazepine-1528

Europe:

Similar to the United States, Oxcarbazepine prices in Europe declined throughout the entire second quarter of 2023. This sustained price decrease was supported by reduced consumer spending, decreased logistical costs, weaker inquiries downstream, and anticipated higher stock supplies. The devaluation of the Euro relative to the USD in May further contributed to negative market sentiment. Traders refrained from additional orders due to surplus supplies and weak demand. Additionally, the cost of raw ingredients for Oxcarbazepine's production has recently decreased, contributing to the overall price decline. Geopolitical tensions between Russia and Ukraine, compounded by rising oil prices, significantly impacted supply chains, leading to economic activity contraction for both consumers and businesses. As June arrived, prices remained unfavorable due to excess supplies and substantial output from major manufacturers. Downstream businesses were compelled to reduce Oxcarbazepine prices to encourage consumption alongside surplus goods.



About Us:

ChemAnalyst is a subsidiary of TechSci Research, which was established in 2008, and has been providing exceptional management consulting to its clients across the globe for over a decade now. For the past four years, ChemAnalyst has been a prominent provider of Chemical commodity prices in more than 15 countries. We are a team of more than 100 Chemical Analysts who are committed to provide in-depth market insights and real-time price movement for 300+ chemical and petrochemical products. ChemAnalyst has reverberated as a preferred pricing supplier among Procurement managers and Strategy professionals worldwide. On our platform, we provide an algorithm-based subscription where users can track and compare years of historical data and prices based on grades and incoterms (CIF, CFR, FOB, & EX-Works) in just one go.


Contact Us:

ChemAnalyst

420 Lexington Avenue, Suite 300,

New York, NY, United States, 10170

Call +1 3322586602

Email: [email protected]

Website: https://www.chemanalyst.com